75 related articles for article (PubMed ID: 28278765)
1. Antimycobacterial, docking and molecular dynamic studies of pentacyclic triterpenes from Buddleja saligna leaves.
Singh A; Venugopala KN; Khedr MA; Pillay M; Nwaeze KU; Coovadia Y; Shode F; Odhav B
J Biomol Struct Dyn; 2017 Sep; 35(12):2654-2664. PubMed ID: 28278765
[TBL] [Abstract][Full Text] [Related]
2. Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges.
Pitaloka DAE; Syaputri Y; Nurlilasari P; Khairunnisa SF; Saallah S
Drug Des Devel Ther; 2024; 18():1969-1979. PubMed ID: 38836115
[TBL] [Abstract][Full Text] [Related]
3. Pentacyclic triterpenoids as potential ACL inhibitors from the rare medicinal plant Semiliquidambar cathayensis.
Wu YF; Zhao ZY; Yang MJ; He YH; Zang Y; Li J; Hu JF; Xiong J
Fitoterapia; 2024 Jul; 176():106018. PubMed ID: 38744385
[TBL] [Abstract][Full Text] [Related]
4. Molecular docking, molecular dynamics simulations and binding free energy studies of interactions between Mycobacterium tuberculosis Pks13, PknG and bioactive constituents of extremophilic bacteria.
Nyambo K; Tapfuma KI; Adu-Amankwaah F; Julius L; Baatjies L; Niang IS; Smith L; Govender KK; Ngxande M; Watson DJ; Wiesner L; Mavumengwana V
Sci Rep; 2024 Mar; 14(1):6794. PubMed ID: 38514663
[TBL] [Abstract][Full Text] [Related]
5. Microwave-assisted extraction of oleanolic acid and ursolic acid from Ligustrum lucidum Ait.
Xia EQ; Wang BW; Xu XR; Zhu L; Song Y; Li HB
Int J Mol Sci; 2011; 12(8):5319-29. PubMed ID: 21954361
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronidase Inhibitory Activity of Pentacylic Triterpenoids from Prismatomeris tetrandra (Roxb.) K. Schum: Isolation, Synthesis and QSAR Study.
Abdullah NH; Thomas NF; Sivasothy Y; Lee VS; Liew SY; Noorbatcha IA; Awang K
Int J Mol Sci; 2016 Feb; 17(2):143. PubMed ID: 26907251
[TBL] [Abstract][Full Text] [Related]
7. A novel pentacyclic triterpene acid from the stem barks of
Silvère Gade I; Nyemb JN; Mahamat A; Atchade AT; Talla E; Laurent S; Henoumont C; Venditti A
Nat Prod Res; 2024 Apr; 38(8):1294-1301. PubMed ID: 36308287
[TBL] [Abstract][Full Text] [Related]
8. Ursolic and Oleanolic Acids: Plant Metabolites with Neuroprotective Potential.
Gudoityte E; Arandarcikaite O; Mazeikiene I; Bendokas V; Liobikas J
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925641
[TBL] [Abstract][Full Text] [Related]
9. Tetracyclic and Pentacyclic Triterpenes with High Therapeutic Efficiency in Wound Healing Approaches.
Ghiulai R; Roşca OJ; Antal DS; Mioc M; Mioc A; Racoviceanu R; Macaşoi I; Olariu T; Dehelean C; Creţu OM; Voicu M; Şoica C
Molecules; 2020 Nov; 25(23):. PubMed ID: 33256207
[TBL] [Abstract][Full Text] [Related]
10. Pentacyclic triterpene acids, rotungenic acid and barbinervic acid, from fresh leaves of
Shimada A; Ueno H; Yamamoto K; Kawabata K; Inagaki M
Nat Prod Res; 2024 May; 38(9):1611-1615. PubMed ID: 36434778
[TBL] [Abstract][Full Text] [Related]
11. Anti-Diabetic Potential of Plant-Based Pentacyclic Triterpene Derivatives: Progress Made to Improve Efficacy and Bioavailability.
Oboh M; Govender L; Siwela M; Mkhwanazi BN
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885816
[TBL] [Abstract][Full Text] [Related]
12. Muscle relaxant and antipyretic effects of pentacyclic triterpenes isolated from the roots of
Khan A; Kashtoh H; Rauf A; Halim SA; Aleem AA; Bahadar H; Shareef H; Mabood F; Khalid A; Baek KH; Al-Harrasi A
Heliyon; 2024 May; 10(9):e30547. PubMed ID: 38726163
[TBL] [Abstract][Full Text] [Related]
13. Unveiling molecular insights: in silico exploration of TLR4 antagonist for management of dry eye syndrome.
Sudhakar K; Dugar N; Jupudi S; Ashwin R; Gowthamarajan K
BMJ Open Ophthalmol; 2024 May; 9(1):. PubMed ID: 38702178
[TBL] [Abstract][Full Text] [Related]
14. Oleanolic acid: an antimycobacterial component of
El Ghallab Y; Dakir M; Aainouss A; El Messaoudi MD; Derfoufi S
Nat Prod Res; 2024 Apr; ():1-7. PubMed ID: 38635391
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of oleanolic and ursolic acids: an update.
Jesus JA; Lago JH; Laurenti MD; Yamamoto ES; Passero LF
Evid Based Complement Alternat Med; 2015; 2015():620472. PubMed ID: 25793002
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative Activity of
Twilley D; Thipe VC; Kishore N; Bloebaum P; Roma-Rodrigues C; Baptista PV; Fernandes AR; Selepe MA; Langhansova L; Katti K; Lall N
Pharmaceuticals (Basel); 2022 Nov; 15(12):. PubMed ID: 36558948
[TBL] [Abstract][Full Text] [Related]
17. Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives.
Venugopala KN; Al-Shar'i NA; Dahabiyeh LA; Hourani W; Deb PK; Pillay M; Abu-Irmaileh B; Bustanji Y; Chandrashekharappa S; Tratrat C; Attimarad M; Nair AB; Sreeharsha N; Shinu P; Haroun M; Kandeel M; Balgoname AA; Venugopala R; Morsy MA
Antibiotics (Basel); 2022 Jun; 11(7):. PubMed ID: 35884084
[TBL] [Abstract][Full Text] [Related]
18. Preparative separation of structural isomeric pentacyclic triterpene oleanolic acid and ursolic acid from natural products by pH-zone-refining countercurrent chromatography.
Wang C; Wang X; Zhao S; Sun W; Tong S
RSC Adv; 2019 Nov; 9(66):38860-38866. PubMed ID: 35540200
[TBL] [Abstract][Full Text] [Related]
19. Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.
Venugopala KN; Chandrashekharappa S; Deb PK; Tratrat C; Pillay M; Chopra D; Al-Shar'i NA; Hourani W; Dahabiyeh LA; Borah P; Nagdeve RD; Nayak SK; Padmashali B; Morsy MA; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Haroun M; Shashikanth S; Mohanlall V; Mailavaram R
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1472-1487. PubMed ID: 34210233
[TBL] [Abstract][Full Text] [Related]
20.
Deb PK; Al-Shar'i NA; Venugopala KN; Pillay M; Borah P
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):869-884. PubMed ID: 34060396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
